Merck (NYSE: MRK) announced that BELSOMRA (suvorexant) is now available at pharmacies in the United States for the treatment of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE